Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Alzheimer's Disease Patients in Assisted Living Facilities
NCT00571064Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd. Primary endpoint: Mini Mental State Examination at Week 12. Started Jan 2008; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00571064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00571064.